The American Medical Association (AMA) had pushed for the CVS–Aetna merger to be blocked because of the increasing body of literature that shows consolidation results in more expensive care with no increase in quality, said Barbara L. McAneny, MD, president of the AMA.
The American Medical Association (AMA) had pushed for the CVS—Aetna merger to be blocked because of the increasing body of literature that shows consolidation results in more expensive care with no increase in quality, said Barbara L. McAneny, MD, president of the AMA.
Transcript
How do you view the vertical integration that has been happening, such as the CVS—Aetna merger?
We had actually requested through the California Department of Insurance and through other testimony that the CVS—Aetna merger not be allowed to take place. We’re appreciative that they at least took the [Medicare] Part D plan away from Aetna, because that was the most egregious conflict of interest.
However, there’s an increasing body of literature that shows that consolidation—either horizontal, where it’s a bunch of hospitals or a bunch of health plans consolidating, or vertical, where it’s health plans and hospitals and pharmacies and other things consolidating—increases their market dominance, which allows them to negotiate higher prices for the exact same service they were delivering before.
So, consolidation has been shown to increase the cost of healthcare, decrease the choice that patients have, and the choice that doctors have, and, if you’re lucky, the quality stays the same.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More